RKDA official logo RKDA
RKDA 1-star rating from Upturn Advisory
Arcadia Biosciences Inc (RKDA) company logo

Arcadia Biosciences Inc (RKDA)

Arcadia Biosciences Inc (RKDA) 1-star rating from Upturn Advisory
$3.64
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $12

1 Year Target Price $12

Analysts Price Target For last 52 week
$12 Target price
52w Low $2.53
Current$3.64
52w High $6.4

Analysis of Past Performance

Type Stock
Historic Profit -54.53%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 5.00M USD
Price to earnings Ratio -
1Y Target Price 12
Price to earnings Ratio -
1Y Target Price 12
Volume (30-day avg) 1
Beta 0.48
52 Weeks Range 2.53 - 6.40
Updated Date 12/14/2025
52 Weeks Range 2.53 - 6.40
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.69

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -97.95%
Operating Margin (TTM) -88.48%

Management Effectiveness

Return on Assets (TTM) -31.48%
Return on Equity (TTM) -64.65%

Valuation

Trailing PE -
Forward PE 36.63
Enterprise Value 566156
Price to Sales(TTM) 0.97
Enterprise Value 566156
Price to Sales(TTM) 0.97
Enterprise Value to Revenue 0.11
Enterprise Value to EBITDA 0.62
Shares Outstanding 1373120
Shares Floating 1361902
Shares Outstanding 1373120
Shares Floating 1361902
Percent Insiders 0.82
Percent Institutions 4.77

About Arcadia Biosciences Inc

Exchange NASDAQ
Headquaters Dallas, TX, United States
IPO Launch date 2015-05-15
CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director Mr. Thomas J. Schaefer C.F.A.
Sector Consumer Defensive
Industry Packaged Foods
Full time employees 9
Full time employees 9

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.